Kypha's Series B Round

Kypha raised a round of funding on May 04, 2018.

Kypha, fka Kentucky Pharmaceuticals, seeks to discover, develop and commercialize innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. The company's plan is for…

Articles about Kypha's Series B Round: